Has catechol-o-methyltransferase genotype (Val158Met) an influence on endocrine, sympathetic nervous and humoral immune systems in women with fibromyalgia syndrome?

Clinical Journal of Pain

Volumn 30, Issue 3, 2014, Pages 199-204

  Fernández De Las Peñas, César ^a   Peñacoba Puente, Cecilia ^a   Cigarán Méndez, Margarita ^a   Díaz Rodríguez, Lourdes ^b   Rubio Ruiz, Belén ^c   Arroyo Morales, Manuel ^d  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b Health Sciences Faculty   (Spain)

^c School of Pharmacy   (Spain)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

A amylase; Cortisol; Fibromyalgia syndrome; Genetics; Immunoglobulin A

Indexed keywords

ALPHA-AMYLASES; CATECHOL O-METHYLTRANSFERASE; FEMALE; FIBROMYALGIA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; HYDROCORTISONE; IMMUNOGLOBULIN A, SECRETORY; MIDDLE AGED; PAIN MEASUREMENT; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; QUESTIONNAIRES; SALIVA; SEVERITY OF ILLNESS INDEX;

EID: 84894066209     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e3182928da0     Document Type: Article

References (43)

1. Lawrence RC, Felson DT, Helmick CG, et al. National Arthritis Work Group. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum. 2008;58:26-35.
2. Branco JC, Bannwarth B, Failde I, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010;39:448-453.
3. Gunnar MR, Quevedo K. The neurobiology of stress and development. Ann Rev Psychol. 2007;58:145-173.
4. Garofalo J, Robinson R, Gatchel R, et al. A pain severity-hypothalamic pituitary-adrenocortical axis interaction: the effects on pain pathways. J Appl Biobehav Res. 2007;12:35-42.
5. McBeth J, Silman AJ, Gupta A, et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a populationbased prospective cohort study. Arthritis Rheum. 2007;56: 360-371.
6. Wingenfeld K, Heim C, Schmidt I, et al. HPA axis reactivity and lymphocyte glucocorticoid sensitivity in fibromyalgia syndrome and chronic pelvic pain. Psychosom Med. 2008; 70:65-72.
7. Taka KM, Cleareb AJ, ORmela J, et al. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol Psychol. 2011;87:183-194.
8. Gur A, Cevik R, Sarac AJ, et al. Hypothalamic-pituitarygonadal axis and cortisol in young women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism. Ann Rheum Dis. 2004;63:1504-1506.
9. Wallace DJ, Linker-Israeli M, Hallegua D, et al. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology. 2001;40:743-749.
10. Russell IJ, Vipraio GA, Michalek JE, et al. Lymphocyte markers and natural killer cell activity in fibromyalgia syndrome: effects of low-dose, sublingual use of human interferon-alpha. J Interferon Cytokine Res. 1999;19:969-978.
11. Carvalhon LSC, Correa H, Silva GC, et al. May genetic factors in fibromyalgia help to identify patients with differentially altered frequencies of immune cells? Clin Experiment Immunol. 2008;154:346-352.
12. Mannisto P, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999;51:593-628.
13. Strous RD, Bark N, Woerner M, et al. Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia. Biol Psychiatry. 1997;41:493-495.
14. Syvanen AC, Tilgmann C, Rinne J, et al. Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of SCOMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland. Pharmacogenetics. 1997;7:65-71.
15. Lee YH, Choi SJ, Ji JD, et al. Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol Int. 2012;32:417-426.
16. Garc?́a-Fructuoso FJ, Lao-Villadó niga JI, Beyer K, et al. Relationship between catechol-O-methyltransferase genotypes and fibromyalgia severity. Rheumatol Clin. 2006;2:168-172.
17. Barbosa FR, Matsuda JB, Mazucato M, et al. Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromialgia patients. Rheumatol Int. 2012;32:427-430.
18. Cohen H, Neumann L, Glazer Y, et al. The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val (158) met and fibromyalgia. Clin Experiment Rheumatol. 2009;27:S51-S56.
19. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160-170.
20. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthr Care Res. 2010;62:600-610.
21. Bijur P, Silveer W, Gallagher JE. Reliability of the visual analogue scale for measurement of acute pain. Acad Emerg Med. 2001;8:1153-1157.
22. Jensen MP, Turbner JA, Romano JM, et al. Comparative reliability and validity of chronic pain intensity measures. Pain. 1999;83:157-162.
23. Esteve-Vives J, Rivera-Redondo J, Salvat-Salvat I, et al. Propuesta de una versió n de consenso del Fibromyalgia Impact Questionnaire (FIQ) para la població n espanola [Consensus proposal of the Fibromyalgia Impact Questionnaire in a Spanish population]. Reumatol Clin. 2007;3:21-24.
24. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol. 1991;18:728-733.
25. Rohleder N, Nater U. Determinants of salivary a-amylase in humans and methodological considerations. Psyconeuroendocrinology. 2009;34:469-485.
26. Nater UM, Rohleder N. Salivary alpha-amylase as a noninvasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology. 2009;34: 486-496.
27. Kirschbaum C, Hellhammer DH. Salivary cortisol in psychoneuroendocrine research: recent developments and applications. Psychoneuroendocrinology. 1994;19:313-333.
28. Vedhara K, Miles J, Bennett P, et al. An investigation into the relationship between salivary cortisol, stress, anxiety and depression. Biol Psychol. 2003;62:89-96.
29. Granger DA, Kivlighan KT, El-Sheikh M, et al. Salivary alphaamylase in bio-behavioral research: recent developments and applications. Ann New York Acad Sci. 2007;1098:122-144.
30. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65-70.
31. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Experiment Rheumatol. 2005;23: S154-S156.
32. Khasar SG, Green PG, Miao FJ, et al. Vagal modulation of nociception is mediated by adrenomedullary epinephrine in the rat. Eur J Neurosci. 2003;17:909-915.
33. Nackley AG, Tan KT, Fecho K, et al. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both b2-and b3-adrenergic receptors. Pain. 2007; 128:199-208.
34. Torpy DJ, Papanicolaou DA, Lotsikas AJ, et al. Responses of the sympathetic nervous system and the hypothalamic-pituitary adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis Rheum. 2000;43:872-880.
35. Riva R, Mork PJ, Westgaard RH, et al. Catecholamines and heart rate in female fibromyalgia patients. J Psychosom Res. 2012;72:51-57.
36. Zubieta JK, Heitzeg MM, Smith YR, et al. COMT val158 met genotype affects m-opioid neurotransmitter responses to a pain stressor. Science. 2003;299:1240-1243.
37. Loggia ML, Jensen K, Gollub RL, et al. The catechol-O-methyltransferase (COMT) val158met polymorphism affects brain responses to repeated painful stimuli. PLoS One. 2011; 6:e27764.
38. Kukutculer N, Aydogdu S, Caglayan S, et al. Salivary and gastric fluid secretory immunoglobulin A and free secretory component concentrations in children with Helicobacter pyloripositive gastritis. J Trop Pediatr. 1998;44:178-180.
39. Taubman B, Mamula P, Sherry DD. Prevalence of asymptomatic celiac disease in children with fibromyalgia: a pilot study. Pediatr Rheumatol Online J. 2011;9:11.
40. Wallace DJ, Hallegua DS. Fibromyalgia: the gastrointestinal link. Curr Pain Headache Rep. 2004;8:364-368.
41. Sjors A, Larsson B, Karlson B, et al. Salivary cortisol response to acute stress and its relation to psychological factors in women with chronic trapezius myalgia: a pilot study. Psychoneuroendocrinology. 2009;35:674-685.
42. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. 2010;363:301-304.
43. Reyes-Gibby CC, Wu X, Spitz M, et al. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol. 2008;9:777-785.